Identification of a candidate genetic variant for the high prevalence of type II diabetes in Polynesians

European Journal of Human Genetics

Volumn 15, Issue 5, 2007, Pages 584-589

  Myles, Sean ^a   Hradetzky, Eva ^a   Engelken, Johannes ^a   Lao, Oscar ^b,c   Nürnberg, Peter ^d   Trent, Ronald J ^e   Wang, Xingyu ^f   Kayser, Manfred ^b   Stoneking, Mark ^a  

^a MAX PLANCK INSTITUTE FOR EVOLUTIONARY ANTHROPOLOGY   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NETHERLANDS FORENSIC INSTITUTE   (Netherlands)

^d UNIVERSITY OF COLOGNE   (Germany)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^f FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA;

ARTICLE; CHINESE; CONTROLLED STUDY; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC VARIABILITY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PACIFIC ISLANDS; PAPUA NEW GUINEA; PHENOTYPE; POLYNESIA; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; DIABETES MELLITUS, TYPE 2; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEAT-SHOCK PROTEINS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYNESIA; POPULATION; PREVALENCE; TRANSCRIPTION FACTORS;

EID: 34247572104     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201793     Document Type: Article

References (54)

1. Zimmet P, Alberti KGMM, Shaw J: Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782.
2. Zimmet P: Globalization, coca-colonization and the chronic disease epidemic: Can the Doomsday scenario be averted? J Internal Med 2000; 247: 301-310.
3. Knowler WC, Bennett P, Hamman R, Miller M: Diabetes incidence and prevalence in Pima Indians: A 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 1978; 108: 497-504.
4. Zimmet PZ, Dowse GK, Finch C, Serjeantson S, King H: The epidemiology and natural history of NIDDM-lessons from the South Pacific. Diabetes Metab Rev 1990; 6: 91-124.
5. O'Dea K: Westernisation, insulin resistance and diabetes in Australian Aborigines. Med J Aust 1991; 155: 258-264.
6. Dowse G, Zimmet P, Finch C, Collins V. Decline in incidence of epidemic glucose intolerance in Nauruans: Implications for the 'thrifty genotype'. Am J Epidemiol 1991; 133: 1093-1104.
7. Zimmet P, Taft P, Guinea A, Guthrie W, Thoma K: The high prevalence of diabetes mellitus on a Central Pacific Island. Diabetologia 1977; 13: 111-115.
8. King H, Zimmet PZ, Bennett P, Taylor R, Raper L: Glucose tolerance and ancestral genetic admixture in six semitraditional Pacific populations. Genet Epidemiol 1984; 1: 315-328.
9. Bellwood P, Renfrew C: Examining the farming/language dispersal hypothesis. Cambridge, United Kingdom: McDonald Institute for Archaeological Research, 2003.
10. Zimmet P, Taylor R, Ram P et al: Prevalence of diabetes and impaired glucose tolerance in the biracial (Melanesian and Indian) population of Fiji: A rural-urban comparison. Am J Epidemiol 1983; 118: 673-688.
11. King H, Finch C, Collins A et al: Glucose tolerance in Papua New Guinea: Ethnic differences, association with environmental and behavioural factors and the possible emergence of glucose intolerance in a highland community. Med J Aust 1989; 151: 204-210.
12. Dowse GK, Spark RA, Mavo B et al: Extraordinary prevalence of non-insulin-dependent diabetes mellitus and bimodal plasma glucose distribution in the Wanigela people of Papua New Guinea. Med J Aust 1994; 160: 767-774.
13. Eason R, Pada J, Wallace R, Henry A, Thornton R: Changing patterns of hypertension, diabetes, obesity and diet among Melanesians and Micronesians in the Solomon Islands. Med J Aust 1987; 146: 465-469.
14. Stoneking M, Jorde LB, Bhatia K, Wilson AC: Geographic variation in human mitochondrial DNA from Papua New Guinea. Genetics 1990; 124: 717-733.
15. Dunn M, Terrill A, Reesink G, Foley RA, Levinson SC: Structural Phylogenetics and the Reconstruction of Ancient Language History. Science 2005; 309: 2072-2075.
16. Kayser M, Brauer S, Weiss G et al: Reduced Y-chromosome, but not mitochondrial DNA, diversity in human populations from West New Guinea. Am J Hum Genet 2003; 72: 281-302.
17. Beizer RA: Prevalence of Abnormal Glucose Tolerance in Six Solomon Islands Populations. Am J Phys Anthropol 1990; 81: 471-482.
18. Zimmet P, Canteloube D, Genelle B et al: The prevalence of diabetes mellitus and impaired glucose tolerance in Melanesians and part-Polynesians in rural New Caledonia and Ouvea. (Loyalty Islands). Diabetologia 1982; 23: 393.
19. Rees JL: Genetics of hair and skin color. Annu Rev Genet 2003; 37: 67-90.
20. Makova K, Norton H: Worldwide polymorphism at the MC1R locus and normal pigmentation variation in humans. Peptides 2005; 26: 1901-1908.
21. Sturm RA, Teasdale RI, Box NF: Human pigmentation genes: identification, structure and consequences of polymorphic variation. Gene 2001; 277: 49-62.
22. Myles S, Somel M, Tang K, Kelso J, Stoneking M: Identifying genes underlying skin pigmentation differences among human populations. Hum Genet 2007; 120: 613-621.
23. Trent RJ, Mickleson KN, Wilkinson T et al: Globin genes in Polynesians have many rearrangements including a recently described gamma gamma gamma gamma. Am J Hum Genet 1986; 39: 350-360.
24. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33: 177.
25. Parikh H, Groop L: Candidate Genes for Type 2 Diabetes. Rev Endocrine Metabolic Disorders 2004; 5: 151-176.
26. Grant SFA, Thorleifsson G, Reynisdottir I et al: Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature 2006; 38: 320-323.
27. Helgason A, Palsson S, Thorleifsson G et al: Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 2007; 39: 218-225.
28. Ke X, Collins A, Ye S: PIRA PCR designer for restriction analysis of single nucleotide polymorphisms. Bioinformatics 2001; 17: 838-839.
29. Weir BS, Cockerham CC: Estimating F-statistics for the analysis of population structure. Evolution 1984; 38: 1358-1370.
30. Matsuzaki H, Dong S, Loi H et al: Genotyping over 100 000 SNPs on a pair of oligonucleotide arrays. Nat Methods 2004; 1: 109-111.
31. Pritchard JK, Stephens M, Donnelly P: Inference of Population Structure Using Multilocus Genotype Data. Genetics 2000; 155: 945-959.
32. Dong Y, Gao W, Nan H et al: Prevalence of Type 2 diabetes in urban and rural Chinese populations in Qingdao, China. Diabet Med 2005; 22: 1427-1433.
33. Jia. WP, Pang C, Chen L et al: Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: The Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 2007; V50: 286-292.
34. Wang Y, Mi J, Shan XY, Wang QJ, Ge KY: Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond) 2007; 31: 177-188.
35. Pan XR, Yang WY, Li GW, Liu J: Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care 1997; 20: 1664-1669.
36. Wong KC, Wang Z: Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res Clin Pr 2006; 73: 126-134.
37. Kayser M, Brauer S, Weiss G et al: Melanesian origin of Polynesian Y chromosomes. Curr Biol 2000; 10: 1237-1246.
38. Kayser M, Brauer S, Cordaux R et al: Melanesian and Asian origins of Polynesians: MtDNA and Y-chromosome gradients across the Pacific. Mol Biol Evol 2006; 23: 2234-2244.
39. Puigserver P, Spiegelman BM: Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α (PGC-1α): Transcriptional Coactivator and Metabolic Regulator. Endocr Rev 2003; 24: 78-90.
40. Yoon JC, Puigserver P. Chen G et al: Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001; 413: 131.
41. Herzig S, Long F, Jhala US et al : CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001; 413 179.
42. Choi YS, Hong JM, Lim S, Ko KS, Pak YK: Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) on mitochondrial transcription factor A (Tfam) promoter. Biochem Biophys Res Commun 2006; 344: 708-712.
43. Pratley RE, Thompson DB, Prochazka M et al: An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J Clin Invest 1998; 101: 1757-1764.
44. Muller YL, Bogardus C, Pedersen O, Baier L: A Gly482Ser Missense Mutation in the Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Is Associated With Altered Lipid Oxidation and Early Insulin Secretion in Pima Indians. Diabetes 2003; 52: 895-898.
45. The International HapMap Consortium: A haplotype map of the human genome. Nature 2005; 437: 1299.
46. Baker P: Migrations, genetics, and the degenerative diseases of South Pacific Islanders; in: Boyce AJ (ed): Migration and Mobility. London: Taylor and Francis, 1984, pp 209-239.
47. Houghton P: The adaptive significance of Polynesian body form. Ann Hum Biol 1990; 17: 19-32.
48. Bindon JR, Baker PT. Bergmann's rule and the thrifty genotype. Am J Phys Anthropol 1997; 104: 201-210.
49. Prior I: The price of civilization. Nutr Today 1971; 6: 2-11.
50. Neel JV: DiabAtes mellitus: a 'thrifty' genotype rendered detrimental by 'progress'? Bull WHO 1962; 77: 694-703.
51. Akey JM, Zhang G, Zhang K, Jin L, Shriver MD: Interrogating a High-Density SNP Map for Signatures of Natural Selection. Genome Res 2002; 12: 1805-1814.
52. Beaumont MA, Balding DJ: Identifying adaptive genetic divergence among populations from genome scans. Mol Ecol 2004; 13: 969-980.
53. Beaumont MA: AdaptatiWn and speciation: what can Fst tell us? Trends Ecol Evol 2005; 20: 435-440.
54. Pollinger JP, Bustamante CD, Fledel-Alon A, Schmutz S, Gray MM, Wayne RK: Selective sweep mapping of genes with large phenotypic effects. Genome Res 2005; 15: 1809-1819.